Letters Response

Rachel Clark and colleagues reply to Eleanor Barry and colleagues

BMJ 2015; 351 doi: http://dx.doi.org/10.1136/bmj.h5301 (Published 08 October 2015) Cite this as: BMJ 2015;351:h5301
  1. Rachel Clark, evidence lead, NHS Diabetes Prevention Programme1,
  2. Jonathan Valabhji, national clinical director for obesity and diabetes2,
  3. Alison Tedstone, national lead diet and obesity and chef nutritionist1,
  4. Louise Ansari, director of prevention of type 2 diabetes3,
  5. Jim O’Brien, national programme director, NHS Diabetes Prevention Programme1
  1. 1Public Health England, London SE1 8UG, UK
  2. 2NHS England, Leeds, UK
  3. 3Diabetes UK, London, UK
  1. jim.obrien{at}phe.gov.uk

Eleanor Barry and colleagues’ editorial relays their concerns about the NHS Diabetes Prevention Programme (DPP).1 Key concerns are dealt with here. The NHS DPP will offer people already identified as being at high risk of developing type 2 diabetes an opportunity to lower their risk through provision of an evidence based behavioural intervention. By failing to implement such a programme, people with known non-diabetic hyperglycaemia are deprived of consistent and evidence based support that would empower them to reduce their risk of type 2 diabetes, questioning our commitment to the public’s health and wellbeing.

We agree that there is a need for multi-level action. Both NHS England and Public Health England (PHE) published plans last year with a focus on improving diet, increasing levels of physical activity, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe